What does it take to prepare for the next influenza pandemic? Researchers like you.
We're hiring a postdoc to join Dr. Troy Sutton's team studying influenza transmission, pandemic risk and vaccines.
@USask@USaskResearch
Apply: vido.applytojobs.ca/research…
Rebuilding human heart tissue. Harnessing #AI for precision care.
@UHN researchers are ‘Pushing the Boundaries of Research’ and redefining what’s possible.
➡️ Discover the innovations shaping the future of health research: uhnresearch.ca/Research-Repo…#RR25#DiscoveryToImpact
Did you know? VIDO has developed 50+ animal models to study infectious diseases! 🧬🐄🐖🐔 These models are critical for research, helping scientists understand diseases & accelerate vaccine and treatment development—protecting both human & animal health. #VIDOis50
Three years ago, we celebrated the completion of construction of our Vaccine Development Centre (VDC). The VDC’s manufacturing capabilities for human and animal vaccines supports Canada’s emergency response for possible future pandemics. #VIDOis50
Share in the thrill of discovery!
Gairdner Science Week is back October 20-23. Join us for a week of groundbreaking science with the world's top experts and #GairdnerAwards winners.
Full event lineup and registration → bit.ly/GairdnerScienceWeek20…#GSW2025
The mantra “location, location, location” isn’t just about real estate.
For life scientists, more than 50% of their productivity can be attributed to the institution where they work, according to a new study. @ScienceCareersscim.ag/44V9Vxo
Just had the pleasure of being interviewed by @Nature on the rise of AI in digital pathology. With growing workloads and global shortages of pathologists, the field is turning to AI not as a luxury—but as a necessity.
Full article: nature.com/articles/d41586-0…
In the article, I discuss how recent advances in foundation models like UNI-2 and CONCH are redefining what’s possible in cancer diagnostics. Trained on hundreds of millions of pathology patches, these models go beyond classification: they enable molecular subtyping, caption generation, and even zero-shot inference.
But while the hype is real, so are the challenges. Cross-site generalization, lack of external validation, and regulatory hurdles remain major barriers. We must invest in robust benchmarking, multi-institutional trials, and trustworthy model design to ensure AI truly supports—not replaces—clinical judgment.
Digital pathology isn’t the future—it’s already here. Let’s make it safe, scalable, and equitable.
@UHN_Research@PMResearch_UHN@VectorInst@UofT
Today we had an excellent chat with several Saskatchewan MLAs sharing the importance of infectious disease research and its worldwide impact. #CanadianResearch
"There is a cohort of talent unlike we have ever seen before that we can compete for."
Dr. @bradwouters, EVP of Science & Research at UHN, gives @CBCTheNational an inside look at Canada Leads, an initiative to recruit 100 top early-career scientists:
cbc.ca/player/play/video/9.6…